poisar

Stocks · News reference

QUICK SPARK: Meet the 15 Worst-Performing Chip Stocks in the Last 7 Sessions

BenzingaPiero Cingari

The worst 15 chip stocks in the last 7 sessions, led by SK Hynix and Arm, as the iShares Semiconductor ETF (SOXX) logs a rare seven-day losing streak.

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
benzinga
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. BenzingaBenzinga News-desk

    Shares of semiconductor and chip companies are trading lower as rising inflation concerns and elevated energy prices fuel expectations for further Fed rate hikes. Elevated borrowing costs could pressure semiconductor manufacturing and AI infrastructure investments while straining customer budgets. The Philadelphia Semiconductor Index (SOX) has declined for seven consecutive trading sessions, matching its longest losing streak since the 2008 financial crisis.

  2. The Motley FoolSara Appino

    Arm vs. Credo Technology Group: Which Semiconductor Stock Is a Better Buy in 2026?

    The article compares two semiconductor companies: Arm, which licenses chip architecture used in billions of devices globally with strong profitability and low risk, and Credo Technology Group, which provides high-speed interconnects for AI data centers with explosive 205% revenue growth but higher customer concentration risk. The author recommends Credo for its superior growth trajectory despite Arm's defensible business model.

  3. The Motley FoolRobert Izquierdo

    Better Artificial Intelligence Stock for 2026: Astera Labs vs. Marvell Technology

    The article compares two semiconductor companies powering AI data centers: Astera Labs, a high-speed connectivity specialist with 115% revenue growth but high customer concentration (70% from one customer), and Marvell Technology, a broader semiconductor provider with 42% growth, lower valuation multiples, and confidence in reaching $70-90 billion in revenue by 2031. The author recommends Marvell due to its more attractive valuation, diversified product portfolio, and long-term growth visibility despite both companies facing customer concentration and geopolitical risks.